CHEMOKINE THERAPEUTICS CORP (CHKT) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 22 transactions totaling $509.1K, demonstrating a bullish sentiment with $501.0K in net insider flow. The most recent transaction on Jan 15, 2009 involved a purchase of 256,900 shares valued at $0.
No significant insider buying has been recorded for CHKT in the recent period.
No significant insider selling has been recorded for CHKT in the recent period.
Based on recent SEC filings, insider sentiment for CHKT is bullish with an Insider Alignment Score of 99/100 and a net flow of $501.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at CHEMOKINE THERAPEUTICS CORP (CHKT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading CHKT stock, having executed 22 transactions in the past 90 days. The most active insider is Hassan Salari (Executive), who has made 12 transactions totaling $470.7K.
Get notified when executives and directors at CHKT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 15, 2009 | Salari Hassan | Executive | Purchase | 256,900 | $N/A | $0 | |
| Jan 12, 2009 | Salari Hassan | Executive | Purchase | 34,000 | $N/A | $0 | |
| Jan 9, 2009 | Salari Hassan | Executive | Purchase | 314,500 | $0.02 | $6.3K | |
| Aug 27, 2008 | Salari Hassan | Executive | Purchase | 100,000 | $0.09 | $9.0K | |
| Aug 27, 2008 | Salari Hassan | Executive | Purchase | 1,290,000 | $0.06 | $77.4K | |
| Aug 27, 2008 | Salari Hassan | Executive | Purchase | 100,000 | $0.09 | $9.0K | |
| Aug 27, 2008 | Salari Hassan | Executive | Purchase | 1,290,000 | $0.06 | $77.4K | |
| Aug 25, 2008 | Rm Evans Donald | Executive | Sale | 9,200 | $0.10 | $920 | |
| Aug 25, 2008 | Rm Evans Donald | Executive | Sale | 25,000 | $0.08 | $2.0K | |
| Aug 25, 2008 | Rm Evans Donald | Executive | Sale | 10,000 | $0.10 | $1.0K | |
| Aug 22, 2008 | Rm Evans Donald | Executive | Sale | 1,450 | $0.11 | $160 | |
| Aug 22, 2008 | Rm Evans Donald | Executive | Purchase | 25,000 | $0.07 | $1.8K | |
| Aug 22, 2008 | Rm Evans Donald | Executive | Purchase | 30,000 | $0.09 | $2.7K | |
| Jun 13, 2008 | M. Kowalchuk George | Executive | Purchase | 666,666 | $0.15 | $100.0K | |
| Jun 13, 2008 | Salari Hassan | Executive | Purchase | 80,000 | $0.15 | $12.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 17 | $505.0K | 71.2% |
Award(A) | 1 | $200.2K | 28.2% |
Sale(S) | 4 | $4.1K | 0.6% |
Insiders at CHEMOKINE THERAPEUTICS CORP are accumulating shares at an accelerated pace. With 6 insiders making 22 transactions totaling $505.0K in purchases versus $4.1K in sales, the net buying activity of $501.0K signals strong executive confidence. Hassan Salari (Executive) leads the buying activity with $470.7K in transactions across all time.